Multivariate modeling of encapsulation and release of an ionizable drug from polymer microspheres

Journal of Pharmaceutical Sciences

Volumn 98, Issue 12, 2009, Pages 4603-4615

  Labouta, Hagar I ^a   El Khordagui, Labiba K ^a   Molokhia, Abdullah M ^b   Ghaly, Ghaly M ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b European Egyptian Company for Pharmaceuticals   (Egypt)

Author keywords

Factorial design; Ionizable drug; Microspheres; Multivariate analysis; Neural networks; Polymeric drug delivery systems; Verapamil HCl

Indexed keywords

EUDRAGIT RS; MICROSPHERE; POLYMER; VERAPAMIL;

ARTICLE; ARTIFICIAL NEURAL NETWORK; CONTROLLED STUDY; DRUG RELEASE; ENCAPSULATION; FACTORIAL ANALYSIS; MOLECULAR WEIGHT; PARAMETER; PARTICLE SIZE; PH MEASUREMENT;

EID: 71649109533     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21753     Document Type: Article

References (44)

1. Li M, Rouaud O, Poncelet D. 2008. Microencapsulation by solvent evaporation: State of the art for process engineering approaches. Int J Pharm 363:26-39.
2. Freitas S, Merkle HP, Gander B. 2005. Microencapsulation by solvent extraction/evaporation: Reviewing the state of the art of microsphere preparation process technology. J Control Release 102:313-332. (Pubitemid 40093756)
3. Lecaroz C, Gamazo C, Renedo MJ, Blanco-Prieto MJ. 2006. Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin. J Microencapsul 23:782-792. (Pubitemid 44811441)
4. Quan JS, Jiang HL, Kim EM, Jeong HJ, Choi YJ, Guo DD, Yoo MK, Lee HG, Cho CS. 2008. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres. Int J Pharm 359:205-210.
5. Jiang HL, Kang ML, Quan JS, Kang SG, Akaike T, Yoo HS, Cho CS. 2008. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization. Biomaterials 29:1931-1939.
6. Sivadas N, O'Rourke D, Tobin A, Buckley V, Ramtoola Z, Kelly JG, Hickey AJ, Cryan S-A. 2008. A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins. Int J Pharm 358:159-167.
7. Elfstrand L, Eliasson A-C, Wahlgren M. 2009. Changes in starch structure during manufacturing of starch microspheres for use in parenteral drug formulations: Effects of temperature treatment. Carbohydr Polymers 75:157-165.
8. Berger R, Rizer R, Barba A, Wilson D, Stewart D, Grossman R, Nighland M, Weiss J. 2007. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: A 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial. Clin Ther 29:1086-1097. (Pubitemid 47198892)
9. Tsung MJ, Burgess DJ. 2001. Preparation and characterization of gelatin surface modified PLGA microspheres. AAPS PharmSciTech 3:E1-E11.
10. Sinha VR, Goyal V, Bhinge JR, Mittal BR, Trehan A. 2003. Diagnostic microspheres: An overview. Crit Rev Ther Drug Carrier Syst 20:431-460.
11. Draghi L, Resta S, Pirozzolo MG, Tanzi MC. 2005. Microspheres leaching for scaffold porosity control. J Mater Sci Mater Med 16:1093-1097. (Pubitemid 41803732)
12. Chen H, Ouyang W, Jones M, Metz T, Martoni C, Haque T, Cohen R, Lawuyi B, Prakash S. 2007. Preparation and characterization of novel polymeric microcapsules for live cell encapsulation and therapy. Cell Biochem Biophys 47:159-168. (Pubitemid 46570707)
13. Parikh RH, Parikh JR, Dubey RR, Soni HN, Kapadia KN. 2003. Poly(D,L-lactide-co-glycolide) microspheres containing 5-fluorouracil: Optimization of process parameters. AAPS PharmSciTech 4:E1-E8.
14. Sun Y, Peng Y, Chen Y, Shukla AJ. 2003. Application of artificial neural networks in the design of controlled release drug delivery systems. Adv Drug Deliv Rev 55:1201-1215. (Pubitemid 37087924)
15. Agatonovic-Kustrin S, Beresford R. 2000. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. J Pharm Biomed Anal 22:717-727. (Pubitemid 30193303)
16. Siepmann J, Siepmann F. 2008. Mathematical modeling of drug delivery. Int J Pharm 364:328-343.
17. Vaithiyalingam S, Khan MA. 2002. Optimization and characterization of controlled release multiparticulate beads formulated with a customized cellulose acetate butyrate dispersion. Int J Pharm 234:179-193. (Pubitemid 34142623)
18. Yuksel N, Turkoglu M, Baykara T. 2000. Modelling of the solvent evaporation method for the preparation of controlled release acrylic microspheres using neural networks. J Microencapsul 17:541-551. (Pubitemid 30705826)
19. Ibric S, Jovanovic M, Djuric Z, Parojcic J, Petrovic SD, Solomun L, Stupar B. 2003. Artificial neural networks in the modeling and optimization of aspirin extended release tablets with Eudragit L 100 as matrix substance. AAPS PharmSciTech 4:E1-E9. (Pubitemid 41086133)
20. Subramanian N, Yajnik A, Murthy RS. 2004. Artificial neural network as an alternative to multiple regression analysis in optimizing formulation parameters of cytarabine liposomes. AAPS PharmSciTech 5:E1-E9. (Pubitemid 41086220)
21. Arulsudar N, Subramanian N, Muthy RS. 2005. Comparison of artificial neural network and multiple linear regression in the optimization of formulation parameters of leuprolide acetate loaded liposomes. J Pharm Pharm Sci 8:243-258. (Pubitemid 41519138)
22. Tanwar YS, Naruka PS, Ojha GR. 2007. Development and evaluation of floating microspheres of verapamil hydrochloride. Braz J Pharm Sci 34:529-534.
23. Liu Z, Ballinger JR, Rauth AM, Bendayan R, Wu XY. 2003. Delivery of an anticancer drug and a chemosensitizer to murine breast sarcoma by intratumoral injection of sulfopropyl dextran microspheres. J Pharm Pharmacol 55:1063-1073. (Pubitemid 36998646)
24. Fitch WP 3rd, Easterling WJ, Talbert RL, Bordovsky MJ, Mosier M. 2007. Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease - a placebo-controlled pilot study. J Sex Med 4:477-484.
25. Helmke CD. 2004. Current topical treatments in wound healing: Part 1. Int J Pharm Compound 8:269.
26. Easterling WJ. 2002. Noninvasive method for treating cellulite through transdermal delivery of calcium channel blocker agents and medicament for use in such method. US Patent, No 085371.
27. Doong H, Dissanayake S, Gowrishankar TR, LaBarbera MC, Lee RC. 1996. The 1996 Lindberg Award. Calcium antagonists alter cell shape and induce procollagenase synthesis in keloid and normal human dermal fibroblasts. J Burn Care Rehabil 17:497-514. (Pubitemid 126730091)
28. Bhavsar MD, Tiwari SB, Amiji MM. 2006. Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design. J Control Release 110:422-430. (Pubitemid 41827496)
29. Uchida T, Yoshida K, Nakada Y, Nagareya N, Konishi Y, Nakai A, Nishikata M, Matsuyama K. 1997. Preparation and characterization of polylactic acid microspheres containing water-soluble anesthetics with small molecular weight. Chem Pharm Bull 45:513-517. (Pubitemid 27150216)
30. Perugini P, Genta I, Conti B, Modena T, Pavanetto F. 2001. Long-term release of clodronate from biodegradable microspheres. AAPS PharmSciTech 2:E1-E9. (Pubitemid 41086075)
31. Wang S, Guo S. 2008. Disodium norcantharidate-loaded poly(epsilon- caprolactone) microspheres. II. Modification of morphology and release behavior. Int J Pharm 353:15-20.
32. Sipos P, Csoka I, Srcic S, Pintye-Hodi K, Eros I. 2005. Influence of preparation conditions on the properties of Eudragit microspheres produced by a double emulsion method. Drug Dev Res 64:41-54. (Pubitemid 40605002)
33. Soppimath KS, Kulkarni AR, Aminabhavi TM. 2001. Encapsulation of antihypertensive drugs in cellulose-based matrix microspheres: Characterization and release kinetics of microspheres and tableted microspheres. J Microencapsul 18:397-409.
34. Siepmann J, Peppas NA. 2001. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 48:139-157. (Pubitemid 32434400)
35. Rojas J, Pinto-Alphandary H, Leo E, Pecquet S, Couvreur P, Fattal E. 1999. Optimization of the encapsulation and release of beta-lactoglobulin entrapped poly(DL-lactide-co-glycolide) microspheres. Int J Pharm 183:67-71. (Pubitemid 29248831)
36. Huang X, Brazel CS. 2001. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. J Control Release 73:121-136. (Pubitemid 32539245)
37. Li S, Doyle P, Metz S, Royce AE, Serajuddin AT. 2005. Effect of chloride ion on dissolution of different salt forms of haloperidol, a model basic drug. J Pharm Sci 94:2224-2231. (Pubitemid 41665282)
38. MaoS, XuJ,CaiC,GermershausO, SchaperA,Kissel T. 2007. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm 334:137-148.
39. Huang YB, Tsai YH, Lee SH, Chang JS, Wu PC. 2005. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int J Pharm 289:87-95.
40. Mao S, Shi Y, Li L, Xu J, Schaper A, Kissel T. 2008. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method. Eur J Pharm Biopharm 68:214-223.
41. Prakobvaitayakit M, Nimmannit U. 2003. Optimization of polylactic-co-glycolic acid nanoparticles containing itraconazole using 23 factorial design. AAPS PharmSciTech 4:E1-E9. (Pubitemid 41086178)
42. Leane MM, Cumming I, Corrigan OI. 2003. The use of artificial neural networks for the selection of the most appropriate formulation and processing variables in order to predict the in vitro dissolution of sustained release minitablets. AAPS PharmSciTech 4:E1-E12. (Pubitemid 41086145)
43. Reis MAA, Sinisterra RD, Belchior JC. 2004. An alternative approach based on artificial neural networks to study controlled drug release. J Pharm Sci 93:418-430.
44. Takayama K, Nagai T. 2000. A novel method based on artificial neural networks for optimizing transdermal drug delivery systems. In: Donald LW, Wise DL, Brannon-Peppas L, Klibanov AM, Langer RS, Mikos AG, Peppas NA, Trantolo DJ, Wnek GE, Yaszemski MJ, editors. Handbook of pharmaceutical controlled release technology. 2 edition. New York: Marcel Dekker, Inc.